(NYSE: DVA) DAVITA's forecast annual revenue growth rate of 1.78% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.79%.
DAVITA's revenue in 2022 is $11,616,351,000.On average, 3 Wall Street analysts forecast DVA's revenue for 2022 to be $1,118,501,775,600, with the lowest DVA revenue forecast at $1,114,577,200,000, and the highest DVA revenue forecast at $1,126,210,162,000.
In 2023, DVA is forecast to generate $1,154,219,330,000 in revenue, with the lowest revenue forecast at $1,145,795,200,000 and the highest revenue forecast at $1,164,946,970,000.